Chardan Capital Stock Recommendations and Price Targets

This is a list of recent ratings by Chardan Capital.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
12/8/2021
DRNA
Dicerna Pharmaceuticals
Downgrade$38.00Buy ➝ NeutralLow
12/2/2021
ABUS
Arbutus Biopharma
Boost Price Target$4.00$5.00 ➝ $5.50BuyHigh
11/24/2021
BTTX
Better Therapeutics
Initiated Coverage$7.00 $17.00BuyHigh
11/23/2021
XCUR
Exicure
Lower Price Target$0.00$7.00 ➝ $2.25BuyLow
11/23/2021
LTRY
Lottery.com
Initiated Coverage$7.00 $14.00BuyMedium
11/23/2021
VLN
Valens Semiconductor
Initiated Coverage$8.00 $13.00BuyHigh
11/23/2021
BMTX
BM Technologies
Initiated Coverage$11.00 $21.00BuyHigh
11/23/2021
LICY
Li-Cycle
Initiated Coverage$12.00 $17.00BuyHigh
11/23/2021
PLBY
PLBY Group
Initiated Coverage$36.00 $49.00BuyLow
11/16/2021
PHGE
BiomX
Lower Price Target$2.00$16.00 ➝ $13.00BuyN/A
11/16/2021
AXLA
Axcella Health
Boost Price Target$3.00$10.00 ➝ $12.00BuyLow
11/16/2021
FIXX
Homology Medicines
Lower Price Target$5.00$30.00 ➝ $25.00BuyHigh
11/12/2021
KLDO
Kaleido Biosciences
Lower Price Target$4.00$15.00 ➝ $11.00BuyLow
11/10/2021
DRNA
Dicerna Pharmaceuticals
Reiterated Rating$38.00 $27.00BuyHigh
11/10/2021
EBS
Emergent BioSolutions
Lower Price Target$41.00$92.00 ➝ $75.00BuyLow
11/5/2021
SABS
SAB Biotherapeutics
Initiated Coverage$9.00 $17.00BuyLow
11/4/2021
ABUS
Arbutus Biopharma
Reiterated Rating$4.00BuyMedium
11/4/2021
GSGTF
GenSight Biologics
Reiterated Rating$7.00BuyLow
11/3/2021
RGNX
REGENXBIO
Lower Price Target$33.00$100.00 ➝ $90.00BuyHigh
11/2/2021
VYGR
Voyager Therapeutics
Lower Price Target$3.00$5.50 ➝ $4.00NeutralLow
11/1/2021
EVLO
Evelo Biosciences
Upgrade$9.00 $12.00Neutral ➝ BuyMedium
10/29/2021
ALNY
Alnylam Pharmaceuticals
Boost Price Target$177.00$190.00 ➝ $200.00BuyHigh
10/19/2021
PHGE
BiomX
Lower Price Target$2.00$28.00 ➝ $16.00BuyN/A
10/17/2021
ABUS
Arbutus Biopharma
Reiterated Rating$4.00BuyHigh
10/13/2021
CRSP
CRISPR Therapeutics
Reiterated Rating$79.00 $171.00BuyLow
10/1/2021
RCOR
Renovacor
Initiated Coverage$9.00 $20.00BuyLow
9/30/2021
EDIT
Editas Medicine
Reiterated Rating$32.00 $75.00BuyMedium
9/24/2021
SLDB
Solid Biosciences
Lower Price Target$2.00$20.00 ➝ $17.00BuyHigh
9/20/2021
FBRX
Forte Biosciences
Upgrade$3.00Sell ➝ BuyMedium
9/16/2021
NTLA
Intellia Therapeutics
Reiterated Rating$116.00 $177.00BuyLow
9/10/2021
PRQR
ProQR Therapeutics
Reiterated Rating$7.00 $18.00BuyMedium
9/7/2021
RCKT
Rocket Pharmaceuticals
Reiterated Rating$25.00BuyMedium
9/3/2021
FBRX
Forte Biosciences
Downgrade$3.00Buy ➝ SellN/A
9/1/2021
NVAX
Novavax
Reiterated Rating$182.00NeutralN/A
8/31/2021
ABUS
Arbutus Biopharma
Reiterated Rating$4.00BuyLow
8/31/2021
MESO
Mesoblast
Lower Price Target$6.00$7.50 ➝ $6.50SellHigh
8/24/2021
TNYA
Tenaya Therapeutics
Initiated Coverage$22.00 $37.00BuyMedium
8/20/2021
IMNM
Immunome
Boost Price Target$17.00$18.00 ➝ $21.00BuyHigh
8/17/2021
TSHA
Taysha Gene Therapies
Lower Price Target$14.00$67.50 ➝ $60.00BuyHigh
8/13/2021
IMVT
Immunovant
Lower Price Target$8.00$55.00 ➝ $22.00BuyHigh
8/13/2021
VINC
Vincerx Pharma
Lower Price Target$11.00$33.00 ➝ $30.00BuyHigh
8/10/2021
DRNA
Dicerna Pharmaceuticals
Lower Price Target$38.00$34.00 ➝ $28.00BuyHigh
8/10/2021
RGNX
REGENXBIO
Reiterated Rating$33.00 $100.00BuyLow
8/10/2021
RCKT
Rocket Pharmaceuticals
Reiterated Rating$25.00 $56.00BuyMedium
8/9/2021
PRQR
ProQR Therapeutics
Lower Price Target$7.00$20.00 ➝ $18.00BuyLow
8/6/2021
ARWR
Arrowhead Pharmaceuticals
Lower Price Target$74.00$97.00 ➝ $94.00BuyHigh
8/6/2021
NTLA
Intellia Therapeutics
Boost Price Target$116.00$130.00 ➝ $177.00BuyLow
8/4/2021
MCRB
Seres Therapeutics
Reiterated Rating$10.00 $16.00BuyMedium
8/4/2021
ALNY
Alnylam Pharmaceuticals
Reiterated Rating$177.00 $190.00BuyMedium
7/30/2021
AXLA
Axcella Health
Reiterated Rating$3.00 $10.00BuyLow
7/30/2021
EVLO
Evelo Biosciences
Lower Price Target$9.00$15.00 ➝ $12.00NeutralHigh
7/30/2021
CRSP
CRISPR Therapeutics
Lower Price Target$79.00$175.00 ➝ $171.00BuyHigh
7/27/2021
QURE
uniQure
Reiterated Rating$29.00$100.00 ➝ $95.00BuyHigh
7/23/2021
ADVM
Adverum Biotechnologies
Lower Price Target$2.00$5.00 ➝ $3.00NeutralHigh
7/23/2021
MCRB
Seres Therapeutics
Lower Price Target$10.00$30.00 ➝ $16.00BuyMedium
7/13/2021
FEMY
Femasys
Initiated Coverage$5.00 $25.00BuyHigh
7/9/2021
SYBX
Synlogic
Initiated Coverage$3.00 $10.00BuyMedium
7/9/2021
KLDO
Kaleido Biosciences
Initiated Coverage$4.00 $15.00BuyHigh
7/9/2021
EVLO
Evelo Biosciences
Initiated Coverage$9.00 $15.00HoldLow
7/9/2021
MCRB
Seres Therapeutics
Initiated Coverage$10.00 $30.00BuyLow
7/9/2021
FBRX
Forte Biosciences
Initiated Coverage$3.00 $105.00BuyHigh
7/7/2021
SIOX
Sio Gene Therapies
Reiterated Rating$1.00BuyMedium
7/7/2021
LOGC
LogicBio Therapeutics
Reiterated Rating$3.00BuyLow
7/7/2021
FIXX
Homology Medicines
Reiterated Rating$5.00BuyMedium
7/7/2021
ACHL
Achilles Therapeutics
Reiterated Rating$5.00BuyMedium
7/7/2021
LBPS
4D pharma
Reiterated Rating$7.00 $40.00BuyMedium
7/7/2021
PDSB
PDS Biotechnology
Reiterated Rating$10.00BuyHigh
7/7/2021
IMVT
Immunovant
Reiterated Rating$8.00BuyLow
7/7/2021
IMTX
Immatics
Reiterated Rating$12.00BuyLow
7/7/2021
IMNM
Immunome
Reiterated Rating$17.00BuyMedium
7/7/2021
IOVA
Iovance Biotherapeutics
Reiterated Rating$19.00BuyHigh
7/7/2021
RCKT
Rocket Pharmaceuticals
Reiterated Rating$25.00BuyLow
7/7/2021
EDIT
Editas Medicine
Reiterated Rating$32.00BuyMedium
7/7/2021
CRSP
CRISPR Therapeutics
Reiterated Rating$79.00BuyMedium
7/7/2021
NTLA
Intellia Therapeutics
Reiterated Rating$116.00BuyMedium
7/7/2021
MRNA
Moderna
Reiterated Rating$283.00BuyHigh
7/1/2021
SIOX
Sio Gene Therapies
Reiterated Rating$1.00BuyN/A
7/1/2021
ADVM
Adverum Biotechnologies
Reiterated Rating$2.00NeutralMedium
7/1/2021
SLDB
Solid Biosciences
Reiterated Rating$2.00BuyHigh
7/1/2021
AGTC
Applied Genetic Technologies
Reiterated Rating$2.00BuyMedium
7/1/2021
VYGR
Voyager Therapeutics
Reiterated Rating$3.00NeutralHigh
7/1/2021
CFRX
ContraFect
Reiterated Rating$3.00BuyMedium
7/1/2021
CBIO
Catalyst Biosciences
Reiterated Rating$1.00BuyHigh
7/1/2021
PRVB
Provention Bio
Reiterated Rating$7.00BuyMedium
7/1/2021
KLDO
Kaleido Biosciences
Reiterated Rating$4.00BuyLow
7/1/2021
FOLD
Amicus Therapeutics
Reiterated Rating$11.00NeutralMedium
7/1/2021
IMVT
Immunovant
Reiterated Rating$8.00BuyMedium
7/1/2021
PASG
Passage Bio
Reiterated Rating$8.00BuyMedium
7/1/2021
EVLO
Evelo Biosciences
Reiterated Rating$9.00NeutralLow
7/1/2021
MGTX
MeiraGTx
Reiterated Rating$21.00BuyLow
7/1/2021
TSHA
Taysha Gene Therapies
Reiterated Rating$14.00BuyHigh
7/1/2021
MCRB
Seres Therapeutics
Reiterated Rating$10.00BuyLow
7/1/2021
QURE
uniQure
Reiterated Rating$29.00BuyHigh
7/1/2021
FBRX
Forte Biosciences
Reiterated Rating$3.00BuyHigh
7/1/2021
RGNX
REGENXBIO
Reiterated Rating$33.00BuyLow
7/1/2021
KRYS
Krystal Biotech
Reiterated Rating$76.00BuyMedium
6/29/2021
IOVA
Iovance Biotherapeutics
Reiterated Rating$19.00 $51.00BuyHigh
6/26/2021
NTLA
Intellia Therapeutics
Boost Price Target$116.00$85.00 ➝ $130.00BuyHigh
6/10/2021
OCGN
Ocugen
Lower Price Target$6.00$8.00 ➝ $4.50NeutralN/A
6/8/2021
PDSB
PDS Biotechnology
Boost Price Target$10.00$11.00 ➝ $15.00BuyN/A